Aditxt, Inc. Amortization of Debt Issuance Costs and Discounts
Aditxt, Inc. (ADTX) reported Amortization of Debt Issuance Costs and Discounts of $42.50 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2025-11-18
- Aditxt, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $42.50K.
- Aditxt, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-06-30 was $8.33K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month |
|---|---|---|---|
| 2025-09-30 | $42.50K 10-Q · filed 2025-11-18 | $50.83K derived: sum of 2 quarters · filed 2025-11-18 | $42.50K 10-Q · filed 2025-11-18 |
| 2025-06-30 | $8.33K 10-Q · filed 2025-08-14 | $8.33K 10-Q · filed 2025-08-14 | |
| 2024-09-30 | $376.90K 10-Q · filed 2024-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |